Robert Atchinson, 10% Owner at Nexvet Biopharma plc (NVET), bought 275,000 shares at $10.00 ($2.8M) on 2014-02-10, disclosed to the SEC on 2015-02-10.
Open-market purchase of $2.8M NVET by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |
| ADXS | SELL | 2017-10-12 | $2.6M | — | Filing → |
| CALA | BUY | 2017-03-24 | $5.0M | — | Filing → |
| HTWR | SELL | 2015-08-04 | $10.1M | — | Filing → |